Showing results (261-270 of 409) with videos related to

Sort By:
Pageof 41
The Journal of Infection|January 9, 2007
Procoagulant and fibrinolytic activity in cerebrospinal fluid from adults with bacterial meningitisMartijn Weisfelt, Rogier M Determann, Jan de Gans, et al.
British Journal of Haematology|April 17, 2022
The use of obinutuzumab and ofatumumab in the treatment of immune thrombotic thrombocytopenic purpuraAndrew J Doyle, Matthew J Stubbs, Will Lester, et al.
British Journal of Haematology|August 8, 2015
Mycophenolate mofetil therapy for severe immune thrombocytopeniaAlice Taylor, Lucy Neave, Shalini Solanki, et al.
Thrombosis and Haemostasis|October 17, 2007
The influence on INRs and coagulation factors of the time span between blood sample collection and intake of phenprocoumon or acenocoumarol: consequences for the assessment of the doseJohanna H H van Geest-Daalderop, Barbara A Hutten, Nathalie C V Péquériaux, et al.
Journal of Thrombosis and Haemostasis : JTH|November 5, 2023
Alterations in the von Willebrand factor/ADAMTS-13 axis in preeclampsiaLucy Neave, Mari Thomas, Rens de Groot, et al.
Journal of Thrombosis and Haemostasis : JTH|May 23, 2022
Anti-PF4 testing for vaccine-induced immune thrombocytopenia and thrombosis (VITT): Results from a NEQAS, ECAT and SSC collaborative exercise in 385 centers worldwideChristopher Reilly-Stitt, Ian Jennings, Steve Kitchen, et al.
Thrombosis and Haemostasis|October 17, 2007
Invasive procedures in the outpatient setting: managing the short-acting acenocoumarol and the long-acting phenprocoumonJohanna H H van Geest-Daalderop, Barbara A Hutten, Nathalie C V Péquériaux, et al.
Thrombosis and Haemostasis|September 9, 2011
Recombinant activated protein C attenuates coagulopathy and inflammation when administered early in murine pneumococcal pneumoniaMarcel Schouten, Cornelis van 't Veer, Joris J T H Roelofs, et al.
Pageof 41